BMJ Open (Jun 2022)

Rationale and design of a prospective study evaluating population pharmacokinetics and pharmacodynamics of rivaroxaban in Chinese patients with non-valvular atrial fibrillation

  • Ming-Ming Yan,
  • Xiao-Qin Liu,
  • Yu-Fei Zhang,
  • Hong-Yan Ding,
  • Ming-Kang Zhong,
  • Chun-Lai Ma

DOI
https://doi.org/10.1136/bmjopen-2021-058378
Journal volume & issue
Vol. 12, no. 6

Abstract

Read online

No abstracts available.